Farman Ali

540 total citations
24 papers, 453 citations indexed

About

Farman Ali is a scholar working on Organic Chemistry, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Farman Ali has authored 24 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 7 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Farman Ali's work include Synthesis and biological activity (8 papers), Click Chemistry and Applications (2 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). Farman Ali is often cited by papers focused on Synthesis and biological activity (8 papers), Click Chemistry and Applications (2 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). Farman Ali collaborates with scholars based in Pakistan, Saudi Arabia and Malaysia. Farman Ali's co-authors include Shahnaz Perveen, Khalid Mohammed Khan, Uzma Salar, Abdul Wadood, Muhammad Taha, Sridevi Chigurupati, Nor Hadiani Ismail, Muhammad Riaz, Muhammad Riaz and Mehreen Ghufran and has published in prestigious journals such as Circulation, Scientific Reports and European Journal of Medicinal Chemistry.

In The Last Decade

Farman Ali

19 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farman Ali Pakistan 11 307 126 93 62 55 24 453
Shahbaz Shamim Pakistan 10 319 1.0× 96 0.8× 98 1.1× 32 0.5× 48 0.9× 20 400
Arshia Arshia Pakistan 13 486 1.6× 245 1.9× 76 0.8× 53 0.9× 41 0.7× 31 686
Liaqat Rasheed Pakistan 15 448 1.5× 157 1.2× 105 1.1× 143 2.3× 162 2.9× 41 635
Muhammad Fakhri Indonesia 10 206 0.7× 93 0.7× 76 0.8× 32 0.5× 31 0.6× 35 380
Shabnam Mahernia Iran 12 264 0.9× 140 1.1× 59 0.6× 35 0.6× 28 0.5× 27 471
Tayyiaba Iqbal Pakistan 13 287 0.9× 88 0.7× 40 0.4× 119 1.9× 137 2.5× 82 443
Milad Noori Iran 11 192 0.6× 60 0.5× 105 1.1× 33 0.5× 56 1.0× 34 326
Keyvan Pedrood Iran 12 258 0.8× 125 1.0× 35 0.4× 48 0.8× 30 0.5× 18 340
Rafaqat Hussain Pakistan 13 319 1.0× 79 0.6× 36 0.4× 144 2.3× 159 2.9× 69 437
Ali Moazzam Iran 13 247 0.8× 95 0.8× 48 0.5× 20 0.3× 32 0.6× 39 370

Countries citing papers authored by Farman Ali

Since Specialization
Citations

This map shows the geographic impact of Farman Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farman Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farman Ali more than expected).

Fields of papers citing papers by Farman Ali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farman Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farman Ali. The network helps show where Farman Ali may publish in the future.

Co-authorship network of co-authors of Farman Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Farman Ali. A scholar is included among the top collaborators of Farman Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farman Ali. Farman Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhen, et al.. (2025). Quantitative Proteomics Investigating the Molecular Responses of Aeromonas hydrophila to Zinc Stress. Journal of Proteome Research. 25(1). 357–367.
2.
3.
4.
Ali, Farman, et al.. (2025). Cardiac Contractility Modulation Therapy and Device Algorithm–related Challenges. Journal of Innovations in Cardiac Rhythm Management. 16(2). 6187–6194.
5.
Ali, Farman, et al.. (2024). Elevated Troponins and Diagnosis of Non-ST-Elevation Myocardial Infarction in the Emergency Department. Cureus. 16(5). e59910–e59910. 1 indexed citations
6.
7.
Ali, Farman, Aling Shen, Waqar Islam, et al.. (2021). Role of MicroRNAs and their corresponding ACE2/Apelin signaling pathways in hypertension. Microbial Pathogenesis. 162. 105361–105361. 5 indexed citations
8.
Cheng, Ying, Jianfeng Chu, Meizhu Wu, et al.. (2021). Baicalin attenuates angiotensin II-induced blood pressure elevation and modulates MLCK/p-MLC signaling pathway. Biomedicine & Pharmacotherapy. 143. 112124–112124. 26 indexed citations
9.
Ali, Farman, et al.. (2020). コバルトフェライトナノ構造を用いた水環境からのコンゴーレッド染料の光触媒分解:開発,特性化,および光触媒性能【JST・京大機械翻訳】. Water Air & Soil Pollution. 231(2). 50. 14 indexed citations
10.
Chu, Jianfeng, Yan Lu, Farman Ali, et al.. (2020). Huoxin Pill Attenuates Cardiac Inflammation by Suppression of TLR4/NF‐κB in Acute Myocardial Ischemia Injury Rats. Evidence-based Complementary and Alternative Medicine. 2020(1). 7905902–7905902. 3 indexed citations
11.
Kanwal, Mohammad Ridwane Mungroo, Ayaz Anwar, et al.. (2020). Synthetic nanoparticle-conjugated bisindoles and hydrazinyl arylthiazole as novel antiamoebic agents against brain-eating amoebae. Experimental Parasitology. 218. 107979–107979. 9 indexed citations
12.
Salar, Uzma, Khalid Mohammed Khan, Sridevi Chigurupati, et al.. (2020). Chalcones and Bis-Chalcones Analogs as DPPH and ABTS Radical Scavengers. Letters in Drug Design & Discovery. 18(3). 249–257. 21 indexed citations
13.
Salar, Uzma, Khalid Mohammed Khan, Almas Jabeen, et al.. (2019). ROS Inhibitory Activity and Cytotoxicity Evaluation of Benzoyl, Acetyl, Alkyl Ester, and Sulfonate Ester Substituted Coumarin Derivatives. Medicinal Chemistry. 16(8). 1099–1111. 5 indexed citations
14.
Khan, Khalid Mohammed, Uzma Salar, Sridevi Chigurupati, et al.. (2018). Chalcones and bis-chalcones: As potential α-amylase inhibitors; synthesis, in vitro screening, and molecular modelling studies. Bioorganic Chemistry. 79. 179–189. 48 indexed citations
15.
Ali, Muhammad, Khalid Mohammed Khan, Uzma Salar, et al.. (2018). Synthesis, in vitro $$\alpha $$ α -glucosidase inhibitory activity, and in silico study of (E)-thiosemicarbazones and (E)-2-(2-(arylmethylene)hydrazinyl)-4-arylthiazole derivatives. Molecular Diversity. 22(4). 841–861. 27 indexed citations
16.
Khan, Momin, Aftab Alam, Khalid Mohammed Khan, et al.. (2018). Flurbiprofen derivatives as novel α-amylase inhibitors: Biology-oriented drug synthesis (BIODS), in vitro, and in silico evaluation. Bioorganic Chemistry. 81. 157–167. 76 indexed citations
17.
Salar, Uzma, Khalid Mohammed Khan, Muhammad Taha, et al.. (2017). Synthesis, in vitro β -glucuronidase inhibitory activity and in silico studies of novel ( E )-4-Aryl-2-(2-(pyren-1-ylmethylene)hydrazinyl)thiazoles. Bioorganic Chemistry. 70. 199–209. 10 indexed citations
18.
Ali, Farman, Khalid Mohammed Khan, Uzma Salar, et al.. (2017). Hydrazinyl arylthiazole based pyridine scaffolds: Synthesis, structural characterization, in vitro α-glucosidase inhibitory activity, and in silico studies. European Journal of Medicinal Chemistry. 138. 255–272. 76 indexed citations
19.
Shamim, Shahbaz, Khalid Mohammed Khan, Uzma Salar, et al.. (2017). 5-Acetyl-6-methyl-4-aryl-3,4-dihydropyrimidin-2(1 H )-ones: As potent urease inhibitors; synthesis, in vitro screening, and molecular modeling study. Bioorganic Chemistry. 76. 37–52. 56 indexed citations
20.
Ali, Farman, Khalid Mohammed Khan, Uzma Salar, et al.. (2016). Dihydropyrimidones: As novel class of β-glucuronidase inhibitors. Bioorganic & Medicinal Chemistry. 24(16). 3624–3635. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shahbaz Shamim Breakdown of academic impact, for papers by Arshia Arshia Breakdown of academic impact, for papers by Liaqat Rasheed Breakdown of academic impact, for papers by Muhammad Fakhri Breakdown of academic impact, for papers by Shabnam Mahernia Breakdown of academic impact, for papers by Tayyiaba Iqbal Breakdown of academic impact, for papers by Milad Noori Breakdown of academic impact, for papers by Keyvan Pedrood Breakdown of academic impact, for papers by Rafaqat Hussain Breakdown of academic impact, for papers by Ali Moazzam
Rankless by CCL
2026